More importantly, ex vivo gene editing therapy is unlikely to be used for molecules expressed by tumor cells, especially solid tumor cells; instead, these molecular targets, such as PD‐L1 and EGFR, and in the case of GDF15 used in this study, are much more numerous and of greater significance in tumor therapy. Here, GDF15 is linked to neoplasm.